Lecanemab Gains FDA Approval for Early Alzheimer Disease. Larkin HD. JAMA 2023 Jan 18. doi: 10.1001/jama.2022.24490.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Larkin HD. Lecanemab Gains FDA Approval for Early Alzheimer Disease. JAMA 2023 Jan 18. doi: 10.1001/jama.2022.24490.
PMID: 36652625